Back
CRISPR Therapeutics AG Vs. Verve Therapeutics Industry Stock Comparison
Sell
45
CRSP
CRISPR Therapeutics AG
Last Price:
52.30
Seasonality Move:
27.39%
Sell
23
VERV
Verve Therapeutics
Last Price:
6.45
Seasonality Move:
59.44%
Sell
45
CRISPR Therapeutics AG (CRSP)
is a Sell
Is CRISPR Therapeutics AG a Buy, Sell or Hold?
- The current CRISPR Therapeutics AG [CRSP] share price is $53.29. The Score for CRSP is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
- CRSP is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
23
Verve Therapeutics (VERV)
is a Sell
Is Verve Therapeutics a Buy, Sell or Hold?
- The current Verve Therapeutics [VERV] share price is $6.08. The Score for VERV is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
- VERV is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CRSP Stock Price Chart
What is CRISPR Therapeutics AG's stock price today?
-
The CRISPR Therapeutics AG share price today is $53.29
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CRSP is experiencing slight selling pressure.
VERV Stock Price Chart
What is Verve Therapeutics's stock price today?
-
The Verve Therapeutics share price today is $6.08
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VERV is experiencing slight selling pressure.
CRSP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -3 | Sell |
| Relative Strength Index (14 RSI): | 34.38 | Sell |
| Chaikin Money Flow: | -437080 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (53.77 - 61.43) | Sell |
| Bollinger Bands (100): | (57.92 - 76.08) | Sell |
VERV Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.08 | Sell |
| Relative Strength Index (14 RSI): | 27.11 | Sell |
| Chaikin Money Flow: | -584911 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (6.09 - 7.89) | Sell |
| Bollinger Bands (100): | (8.6 - 14.8) | Sell |
CRSP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 54.82 | Sell |
| 20-day SMA: | 56.05 | Sell |
| 50-day SMA: | 66.2 | Sell |
| 200-day SMA: | 59.36 | Sell |
| 8-day EMA: | 55.02 | Sell |
| 20-day EMA: | 57.12 | Sell |
| 50-day EMA: | 62.35 | Sell |
| 200-day EMA: | 61.92 | Sell |
VERV Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 6.19 | Sell |
| 20-day SMA: | 6.62 | Sell |
| 50-day SMA: | 10.4 | Sell |
| 200-day SMA: | 12.56 | Sell |
| 8-day EMA: | 6.26 | Sell |
| 20-day EMA: | 7.02 | Sell |
| 50-day EMA: | 9.11 | Sell |
| 200-day EMA: | 12.8 | Sell |
CRISPR Therapeutics AG Earnings Growth & CRSP Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.54 per share, a decrease next quarter of $0.17 per share, a decrease this year of $2.67 per share, and an increase next year of $1.62 per share.
Verve Therapeutics Earnings Growth & VERV Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.17 per share, a decrease next quarter of $0.13 per share, an increase this year of $0.54 per share, and a decrease next year of $0.43 per share.
CRISPR Therapeutics AG Technical Analysis
| Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 25 | 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Verve Therapeutics Technical Analysis
| Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 25 | 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||